Search The Journal... as journal on MyScienceWork's publications...

Osteonecrosis of the jaw and nonmalignant disease: is there an association with rheumatoid arthritis?

Lescaille, G. Coudert, A. E. Baaroun, V. Javelot, M.-J. Martine Cohen-Solal Ariane Berdal Goudot, P. Azerad, J. Ruhin, B. Descroix, V. ...

Published in The Journal of Rheumatology

Objective: To review cases of bisphosphonate-related osteonecrosis of the jaw (BRONJ) occurring in association with benign disease and to describe and compare the clinical course and outcome for patients with BRONJ and rheumatoid arthritis (RA) or osteoporosis. Methods: We retrospectively reviewed observations of all patients referred for treatm...

The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.

Merkel, Peter A Aydin, Sibel Z Boers, Maarten Direskeneli, Haner Herlyn, Karen Seo, Philip Suppiah, Ravi Tomasson, Gunnar Luqmani, Raashid A

Published in The Journal of rheumatology

There has been a marked increase in the past 15 years in the number and quality of clinical trials in the idiopathic inflammatory vasculitides, especially the small-vessel vasculitides known as antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis [AAV; granulomatosis, with polyangiitis (Wegener's)]. These trials have been conducted ...

Systemic vasculitis in patients with hepatitis C virus infection with and without detectable mixed cryoglobulinemia.

Terrier, Benjamin Sène, Damien Dechartres, Agnès Saadoun, David Ortonne, Nicolas Rouvier, Philippe Musset, Lucile Rigon, Matthieu Resche Maisonobe, Thierry Cacoub, Patrice ...

Published in The Journal of Rheumatology

HCV-related systemic vasculitis may occur in the absence of detectable MC. Our findings suggest that such vasculitis probably results from immune complex-mediated mechanisms, and that the therapeutic management of such vasculitis should be similar to that of HCV-MC vasculitis.

Mimics of vasculitis: vascular Ehlers-Danlos syndrome masquerading as polyarteritis nodosa.

Badawi, Ramy A Brent, Lawrence H Feinstein, David E

Published in The Journal of rheumatology

The gap between practice and guidelines in the choice of first-line disease modifying antirheumatic drug in early rheuma...

Benhamou, Mathilde Rincheval, Nathalie Roy, Carine Foltz, Violaine Rozenberg, Sylvie Sibilia, Jean Schaeverbeke, Thierry Bourgeois, Pierre Ravaud, Philippe Fautrel, Bruno ...

Published in Immunity

There is a substantial gap between CPG and rheumatologists' daily practice concerning the first DMARD to prescribe in early RA. This is explained mainly by diagnostic uncertainty. More attention should be paid in future guidelines to the diagnostic difficulties of early RA.

Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumat...

Tubach, Florence Ravaud, Philippe Beaton, Dorcas Boers, Maarten Bombardier, Claire Felson, David T van der Heijde, Desireé Wells, George Dougados, Maxime

Published in Immunity

The concepts of minimal clinically important improvement (MCII) and patient acceptable symptomatic state (PASS) could help in interpreting results of trials involving patient-reported outcomes by translating the response at the group level (change in mean scores) into more clinically meaningful information by addressing the patient level as "therap...